DIETARY SUPPLEMENT HEALTH AND EDUCATION ACT

Analyses

False and Misleading—FDA's Report ``Unsubstantiated Claims and Documented Health Hazards in the Dietary Marketplace'', S16817-S16820 [20NO]

Articles and editorials

Recommendations for the Use of Folic Acid To Reduce the Number of Cases of Spina Bifida and Other Neural Tube Defects, S16826-S16828 [20NO]

Vitamin E Consumption and the Risk of Coronary Disease in Women, S16820-S16826 [20NO]

Bills and resolutions

Enact (see S. 784), S4561 [7AP]

FDA: moratorium on the issuance of regulations relative to dietary supplements (see S. 1762), S16719 [20NO]

Remarks in Senate

Enact (S. 784), S4577, S4580 [7AP], S5243 [29AP], S11677 [14SE], S13098 [5OC], S14837 [2NO], S17049 [23NO]

FDA: moratorium on the issuance of regulations relative to dietary supplements (S. 1762), S16816, S16868 [20NO]

Texts of

S. 784, provisions, S4578-S4580 [7AP]

S. 1762, Dietary Supplement Regulation Moratorium Act, S17202 [24NO]